youtube_live
Q3 2026 earnings • in 5 days
See detailschevron_right
TMO:NYSE
Thermo Fisher Scientific Inc
$685.71
arrow_downward
-1.55%(-10.78) 1D
Oct 16, 12:15:53 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMO...
Open
$692.26
High
$699.20
Low
$683.63
Mkt. cap
253.76B
Avg. vol.
2.30M
Volume
748.81K
Dividend
0.27%
Quarterly dividend
$0.47
Ex-dividend date
Jun 15, 2026
P/E ratio
36.91
52-wk high
$704.00
52-wk low
$435.27
EPS
$18.58
Beta
0.87
Shares outstanding
369.75M
No. of employees
125K
Open
$692.26
High
$699.20
Low
$683.63
Mkt. cap
253.76B
Avg. vol.
2.30M
Volume
748.81K
Dividend
0.27%
Quarterly dividend
$0.47
Ex-dividend date
Jun 15, 2026
P/E ratio
36.91
52-wk high
$704.00
52-wk low
$435.27
EPS
$18.58
Beta
0.87
Shares outstanding
369.75M
No. of employees
125K
News stories
From web sources and news partners
Zacks
·
3 hours ago
What Analyst Projections for Key Metrics Reveal About Thermo Fisher (TMO) Q3 Earnings
Zacks
·
3 hours ago
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Seeking Alpha
·
4 hours ago
Thermo Fisher: Strong Growth, Even Higher Stock Price (NYSE:TMO)
News Corp
·
19 hours ago
Gilead and Cardinal Health Stocks Jump to Record Highs. Why Healthcare Is on a Tear.
About Thermo Fisher Scientific Inc
CEO-
Employees125K
Founded1956
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websitethermofisher.com
Analyst ratings
Based on 18 analysts giving stock ratings to TMO in the past 3 months
Strong buy
Buy
15
Hold
3
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for TMO in the last 3 months.
Highest
Current $685.71
$780.00 (+13.75%)
Average
$683.94 (-0.26%)
Lowest
$575.00 (-16.15%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Daniel Brennan TD Cowen | Buy | Maintained | $760.00 | +10.8% | 10/13/2026 |
Kallum Titchmarsh Morgan Stanley | Buy | Reiterated | $730.00 | +6.5% | 10/13/2026 |
Eve Burstein Bernstein | Hold | Maintained | $575.00 | -16.1% | 10/12/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $745.00 | +8.6% | 10/09/2026 |
Michael Ryskin Bank of America Securities | Buy | Maintained | $745.00 | +8.6% | 10/09/2026 |
Luke Sergott Barclays | Buy | Maintained | $750.00 | +9.4% | 10/07/2026 |
Justin Bowers Deutsche Bank | Buy | Reiterated | $720.00 | +5% | 09/25/2026 |
Unknown Analyst Goldman Sachs | Buy | Maintained | $780.00 | +13.8% | 09/20/2026 |
Evan Stampler Wells Fargo | Buy | Reiterated | $660.00 | -3.7% | 09/17/2026 |
Daniel Arias Stifel Nicolaus | Buy | Maintained | - | - | 09/15/2026 |
Unknown Analyst UBS | Buy | Upgraded | $730.00 | +6.5% | 09/08/2026 |
Doug Schenkel UBS | Buy | Initiated | $730.00 | +6.5% | 09/08/2026 |
Michael Luo CFA CLSA | Buy | Initiated | $748.00 | +9.1% | 09/03/2026 |
Casey Woodring J.P. Morgan | Buy | Maintained | $690.00 | +0.6% | 07/28/2026 |
Jill Wu CMB International Securities | Buy | Maintained | $660.00 | -3.7% | 07/27/2026 |
David Westenberg Piper Sandler | Hold | Maintained | $600.00 | -12.5% | 07/27/2026 |
Aristotelis Moutopoulos DZ BANK AG | Buy | Maintained | $630.00 | -8.1% | 07/27/2026 |
Dan Leonard RBC Capital | Hold | Maintained | $580.00 | -15.4% | 07/23/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 07/24/2026 |
Tycho Peterson Jefferies | Buy | Reiterated | $630.00 | -8.1% | 07/23/2026 |
Brandon Couillard Wells Fargo | Buy | Reiterated | $615.00 | -10.3% | 07/23/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $570.00 | -16.9% | 07/06/2026 |
Sidharth Sahoo HSBC | Hold | Downgraded | $540.00 | -21.2% | 06/03/2026 |
Michael Polark Wolfe Research | Buy | Initiated | $535.00 | -22% | 06/01/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $585.00 | -14.7% | 05/21/2026 |
Unknown Analyst RBC Capital | Hold | Initiated | $490.00 | -28.5% | 05/14/2026 |
Hans Engel Erste Group | Hold | Maintained | - | - | 05/05/2026 |
Bill Selesky Argus Research | Buy | Maintained | $560.00 | -18.3% | 04/30/2026 |
Unknown Analyst Argus Research | Buy | Maintained | $560.00 | -18.3% | 04/30/2026 |
David Toung Argus Research | Buy | Maintained | $560.00 | -18.3% | 04/30/2026 |
Catherine Ramsey Schulte Robert W. Baird | Buy | Maintained | $639.00 | -6.8% | 04/24/2026 |
Natalya Davies Rothschild & Co Redburn | Buy | Maintained | $620.00 | -9.6% | 04/17/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $685.00 | -0.1% | 04/06/2026 |
Next call in 5 days
Wed, Oct 21, 1:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $6.40
Revenue / Est. (USD)
- / 11.93B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 11.12B | 12.22B | 11.00B | 11.99B |
Cost of goods sold | 6.53B | 7.17B | 6.56B | 7.08B |
Cost of revenue | 6.53B | 7.17B | 6.56B | 7.08B |
Research and development expenses | 346.00M | 356.00M | 336.00M | 364.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.10B | 2.24B | 2.14B | 2.30B |
Operating expense | 2.45B | 2.46B | 2.48B | 2.66B |
Total operating expenses | 8.98B | 9.63B | 9.04B | 9.74B |
Operating income | 2.14B | 2.59B | 1.97B | 2.25B |
Other non operating income | -32.00M | -32.00M | -15.00M | 13.00M |
EBT including unusual items | 1.83B | 2.12B | 1.73B | 1.91B |
EBT excluding unusual items | 2.03B | 2.44B | 1.83B | 2.05B |
Income tax expense | 207.00M | 153.00M | 70.00M | 167.00M |
Effective tax rate | 11.32% | 7.21% | 4.06% | 8.75% |
Other operating expenses | - | -135.00M | 1.00M | - |
Net income | 1.62B | 1.96B | 1.65B | 1.74B |
Net profit margin | 14.53% | 16.08% | 15.00% | 14.47% |
Earnings per share | 5.79 | 6.57 | 5.44 | 6.03 |
Interest and investment income | 234.00M | 258.00M | 233.00M | 207.00M |
Interest expense | -347.00M | -365.00M | -354.00M | -401.00M |
Net interest expenses | -113.00M | -107.00M | -121.00M | -194.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 2.82B | 3.31B | 2.70B | 3.07B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1